N‐acteyl‐ß‐D‐glucosaminidase and kidney injury molecule‐1: New predictors for long‐term progression of chronic kidney disease in patients with heart failure
- 17 May 2016
- journal article
- Published by Wiley in Nephrology
- Vol. 21 (6) , 490-498
Abstract
Aim: Patients with chronic heart failure (CHF) are often characterized by the cardiorenal syndrome (CRS). The aim of the present study was to assess whether novel markers of kidney injury are able to predict progression of chronic kidney disease (CKD) in patients with CHF.Methods: New renal biomarkers, N‐acteyl‐ß‐D‐glucosaminidase (NAG), kidney injury molecule‐1 (KIM‐1) and Neutrophil Gelatinase‐Associated Lipocalin (NGAL), were assessed from urine samples of 149 patients with chronic heart failure. During a 5‐year‐follow‐up, renal function was assessed by creatinine and estimated glomerular filtration rate (eGFR CKD EPI) and was available for 138 patients. Further, data regarding all‐cause mortality was obtained.Results: Twenty‐six patients (18.8%) developed a progression of CKD during the follow‐up period, as defined by decline in eGFR category accompanied by a ≥25% drop in eGFR form baseline. No difference regarding age, sex, body mass index, hypertension, diabetes or EF was present between patients with and without CKD progression (each P = n.s.). At baseline, creatinine concentrations and eGFR were significantly different between both groups (sCr: 1.50 ± 0.67 vs 1.04 ± 0.37, P = < 0.001; eGFR: 47.8 ± 12.3 vs. 77.3 ± 23.5 mL/min per 1.73m2, each P < 0.001). In a Kaplan–Meier‐analysis, KIM‐1 and NAG were significant predictors for CKD progression (both P < 0.05). In Cox regression analysis, NAG > median (OR 3.25,P = 0.013), initial eGFR (OR 0.94, P < 0.001) and diuretic use (OR 3.92, P = 0.001) were independent predictors of CKD progression. Further, KIM‐1 and NAG were also independent predictors of a combined endpoint of CKD progression and all‐cause mortality by Cox regression analysis (each P < 0.05). The combination of both markers showed additive value regarding both endpoints. NGAL showed no association with CKD progression.Conclusions: During long‐term follow‐up chronic heart failure patients with CKD show a relevant disease progression. The current study emphasizes a strong association of the tubular biomarkers NAG and KIM‐1 with CKD progression in chronic heart failure and suggests their usefulness as cardiorenal markers.Keywords
This publication has 25 references indexed in Scilit:
- Lack Of Significant Renal Tubular Injury Despite Acute Kidney Injury in Acute Decompensated Heart FailureEuropean Journal of Heart Failure, 2012
- Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rateHeart, 2010
- Enzymuria determination in children treated with aminoglycosides drugsHuman & Experimental Toxicology, 2008
- Cardiorenal SyndromeJACC, 2008
- Kidney injury molecule-1 in acute kidney injury and renal repair: a reviewJournal of Chinese Integrative Medicine, 2008
- Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensusNature Clinical Practice Nephrology, 2008
- High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: A Report From the ADHERE DatabaseJournal of Cardiac Failure, 2007
- Neutrophil-Gelatinase-Associated Lipocalin and Renal Function after Percutaneous Coronary InterventionsAmerican Journal of Nephrology, 2006
- The Clinical Challenge of Cardiorenal SyndromeCirculation, 2004
- Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after InjuryJournal of Biological Chemistry, 1998